December 2022 - Sansum Diabetes Research Institute

Dexcom G7 Receives FDA Clearance; SDRI Served as Pivotal Site for Clinical Trials

Dec 9, 2022 | News, Press Releases

BREAKING NEWS: Dexcom G7 Continuous Glucose Monitor has received FDA approval! SDRI conducted the pivotal clinical research trials for the G7 Continuous Glucose Monitor Sansum Diabetes Research Institute’s (SDRI) mission is to improve the lives of people...

November is National Diabetes Awareness Month

Dexcom G7 Receives FDA Clearance; SDRI Served as Pivotal Site for Clinical Trials

Recent Posts

Archives